An Italian company, Diasorin, has received approval from FDA for a 60 minutes COVID-19 test

The kit consists of a mixture of ready-to-use reagents, does not require the traditional nucleic acid extraction procedure and allows rapid detection, in just over an hour compared to 7 hours currently required by traditional extraction and amplification technologies, facilitating decisions on isolation of infected patients.